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Abstract 
This study was designed to determine the effectiveness of whole-body vibration (WBV) and intermittent 
parathyroid hormone (iPTH) in combination against estrogen deficiency-induced osteoporosis. Female 
C57BL/6J mice were bilaterally ovariectomized (OVX, n = 40) or sham-operated (sham-OVX, n = 8) at 9 
weeks of age. Two weeks later, the OVX mice were randomly divided into four groups (n = 10 each): the 
control group (c-OVX) and groups treated with iPTH (p-OVX), WBV (w-OVX) and both (pw-OVX). 
The p-OVX and pw-OVX groups were given human PTH (1–34) at a dose of 30 µg/kg/day. The w-OVX 
and pw-OVX groups were exposed to WBV at an acceleration of 0.3 g and 45 Hz for 20 min/day. All 
mice were euthanized after the 18-day treatment, and the left tibiae were harvested. The proximal 
metaphyseal region was µCT-scanned, and its cortical bone cross-section was analyzed by Fourier 
transform infrared microspectroscopy and nanoindentation testing. A single application of iPTH or WBV 
to OVX mice had no effect on bone structure or material properties of cortical bone, which were 
compromised in comparison with those in sham-OVX mice. The combination of iPTH and WBV 
improved trabecular bone volume, thickness and connectivity in OVX mice. Although the combined 
treatment failed to improve cortical bone structure, its mineral maturity and hardness restored to the levels 
observed in sham-OVX mice. There was no evidence of interaction between the two treatments, and the 
combined effects seemed to be additive. These results suggest combining WBV with iPTH has potential 
for treating postmenopausal osteoporosis. 
 
Keywords: postmenopausal osteoporosis, low-magnitude high-frequency vibration, parathyroid 
hormone, micro-computed tomography, infrared microspectroscopy, nanoindentation testing 
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Introduction 
With the global aging population, osteoporosis has become an ever more important healthcare 
issue in the elderly. Postmenopausal women, in particular, are frequently susceptible to osteoporosis 
owing to a low peak bone mass coupled with menopausal bone loss. Worldwide there are more than 200 
million women with postmenopausal osteoporosis [1, 2]. The X-ray diagnosis of the lumbar spine and the 
femoral neck in a large-scale population-based cohort study in Japan [3, 4] revealed that 9.8 million 
women aged 40 years and above suffered from osteoporosis. Osteoporosis increases bone fragility and 
susceptibility to fracture and leads to increased morbidity and mortality as well as decreased functional 
ability or quality of life. Therefore, the prevention and treatment of osteoporosis in postmenopausal 
women have economic and health benefits.  
In early postmenopausal women, estrogen deficiency increases bone turnover with a 
prevalence of bone resorption over formation [5, 6]. A number of studies have focused on the efficacy of 
anti-resorptive or anabolic pharmacological treatments for postmenopausal osteoporosis [7–9]. Of these 
treatments, parathyroid hormone (PTH) is the first bone anabolic drug to be approved by the Food and 
Drug Administration [10]. When injected once daily, PTH produces anabolic effects on the skeleton by 
activating pro-differentiating and pro-survival signaling in osteoblastic cells [11]. This so-called 
intermittent PTH (iPTH) induces an anabolic response in postmenopausal women [12, 13], and also in 
ovariectomized (OVX) rodents [14, 15], which mimic postmenopausal bone loss [16]. 
Estrogen deficiency in postmenopausal osteoporosis alters estrogen receptor expressions [17, 
18], thereby elevating bone mechano-responsiveness. Thus, mechanical stimuli may be potent 
non-pharmacological alternatives for treating postmenopausal osteoporosis. In particular, whole body 
vibration (WBV), which exposes subjects to low-intensity (< 1 × g in general; g = 9.81 m/s2), 
high-frequency mechanical stimuli for short durations [19, 20], is more accessible than other loading 
modalities for some elderly patients for whom exercising is contraindicated or difficult. Some evidence 
has been reported for the mechano-responsiveness of sensitized bone to WBV [21] and for the 
effectiveness of WBV against bone loss in OVX rodents [22, 23]. Postmenopausal women can also 
benefit from WBV although its therapeutic outcome appears to be less pronounced in elderly than in 
younger patients [24, 25]. 
Several studies have indicated that iPTH also sensitizes bone cells to mechanical stimuli and 
lowers the bone-modeling threshold of mechanical strain, thereby enhancing mechanically stimulated 
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bone formation [26–28]. Furthermore, mechanical stimulation is thought to increase bone strength in an 
efficient manner by localizing the anabolic effects of iPTH to biomechanically relevant sites [29, 30]. 
Considering these benefits of using iPTH and mechanical stimuli in combination, it is anticipated that the 
concurrent use of WBV and iPTH will exert a synergistic or additive effect in preventing postmenopausal 
bone loss. To our knowledge, however, there has been no study on the effect of WBV combined with 
iPTH on postmenopausal osteoporosis. To address this shortcoming, we evaluated the effect of WBV, 
iPTH, and their combination on OVX-induced osteoporosis in mice. Micro-computed tomography (µCT), 
Fourier transform infrared microspectroscopy (FTIR-MS), and nanoindentation testing were used to 
assess bone structural, chemical, and mechanical properties, respectively. 
 
Method and Materials 
General Procedures 
Experiments were conducted in accordance with the guiding principles of the American 
Physiological Society and with the approval of the Animal Research Committee of Osaka University 
Graduate School of Engineering Science. 
Female C57BL/6J mice (CLEA Japan, Tokyo, Japan) were bilaterally ovariectomized (OVX, n 
= 40) or sham-operated (sham-OVX, n = 8) under anesthesia by an intraperitoneal injection of ketamine 
(100 mg/kg) and xylazine (10 mg/kg) at the age of 9 weeks. Mice were then single-housed in a plastic 
cage under controlled conditions (12-hour light/dark cycle, 25°C, 60% humidity) and allowed free access 
to a standard diet (CE-2; CLEA Japan) and tap water. 
Two weeks later, the OVX mice were randomly divided into four groups (n = 10 each): the 
control group (c-OVX) and the groups treated with WBV (w-OVX), iPTH (p-OVX) and WBV/iPTH 
(pw-OVX). The p-OVX and pw-OVX groups were subcutaneously administered recombinant human 
PTH (1–34) (Bachem California, Inc., Torrance, CA) dissolved in a vehicle of 0.2% bovine serum 
albumin and 0.1% 1 mN hydrochloric acid in 0.9% saline to form a solution of 10 µg/ml for delivery [31], 
at a dose of 30 µg/kg/day. The c-OVX, w-OVX and sham-OVX groups received the delivery vehicle only 
at an equal volume to the p-OVX and pw-OVX groups. Additionally, mice in the w-OVX and pw-OVX 
groups were put in a compartmented cage on the vibration platform (Big-Wave; Asahi Seisakujo, Tokyo, 
Japan) and exposed daily to 20-min of vertical WBV at 45 Hz with a peak-to-peak acceleration of 0.3 g. 
An earlier study reported the efficacy of WBV at this frequency and acceleration in the growing skeleton 
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of 8-week-old female mice [32]. Mice in the c-OVX, p-OVX, and sham-OVX groups were placed on the 
vibration platform for 20 min but in a non-operating state. The vehicle or PTH was administered 30 min 
before each WBV session. These interventions were introduced once daily at the same hour. After 18 
days of treatment (one month after OVX), mice were euthanized by an overdose of pentobarbital sodium. 
The left tibiae were harvested, dissected free of soft tissue, wrapped with moistened saline gauze, and 
stored at −30°C until analysis. 
 
µCT Analysis 
The specimens were slowly thawed and then encapsulated in an acrylic tube filled with saline. 
Next, the proximal part of the tibiae was scanned using a µCT system (SMX-1000/VCT; Shimadzu, 
Kyoto, Japan). The scanning parameters were: 90 keV, 110 µA, 600-ms integration time and 1,200 
projections over 360°. Image reconstruction was carried out for a 1.5-mm-long section of the metaphysis 
distal to the growth plate (Fig. 1A), providing 167 contiguous slice images of cross-section composed of 
512 × 512, 9-µm cubic voxels with an 8-bit gray-scale resolution. Bone was segmented from background, 
marrow or soft tissue residues by binarization using Otsu’s method [33]. The outer and inner borders of 
the cortical bone were determined by raster scanning in multiple directions after filling all bone pores, and 
the trabecular and cortical compartments were segmented (Fig. 1B). The following structural indices were 
determined: cortical bone volume (Cb.V, mm3), medullary tissue volume (Mt.V, mm3), cortical bone 
thickness (Cb.Th, µm), trabecular bone volume fraction (Tb.Vf, %), trabecular bone thickness (Tb.Th, 
µm), trabecular bone number (Tb.N, mm–1) and trabecular bone connectivity density (Tb.Cd, mm–3). A 
three-dimensional method [34] was used for computing Cb.Th, Tb.Th and Tb.N. The BoneJ plugin 1.3.14 
[35] for ImageJ 1.49v was used for calculating these indices. 
 
FTIR-MS 
After µCT, the proximal epimetaphyseal portion of the specimen was embedded in 
polymethylmethacrylate (PMMA) without ethanol fixation to avoid possible deterioration of collagen 
[36]. The longitudinal position showing the midsection of the metaphysis (Fig. 1A) was marked on the 
cortical surface prior to embedding. After polymerization, using an 800-grit SiC abrasive paper disc, the 
proximal surface of an embedded specimen was sanded perpendicularly to the tibial long axis in 
deionized water until the position mark was reached. The surface was further polished sequentially with 
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1200- and 4000-grit abrasive paper discs, 1-µm diamond suspension (DP-Spray P; Struers, Ballerup, 
Denmark) and finally with 0.05-µm alumina suspension (AP-D; Struers, Ballerup, Denmark) to a state 
close to a mirror surface. The proximal cross section was ultrasonically cleaned to remove surface debris 
and heated at 50°C for 24 h in ambient air to prevent the enzymatic degradation of collagen [36]. 
The mirror-polished cortical cross-section was analyzed for chemicals using an FTIR-MS 
system (IRPrestige-21/AIM-8800; Shimadzu, Kyoto, Japan) in reflection mode. Spectra were collected 
from three 30 × 30-µm2 regions, each at the anterior, posterior, medial and lateral cortices (Fig. 2A) under 
the conditions of 4 cm−1 spectral resolution and 50 scans per point. The data obtained were corrected for 
background and converted to absorbance units by the Kramers–Kronig transformation (Fig. 2B). The 
following chemical indices were determined: mineral/matrix ratio, estimated as the integrated area ratio 
of the phosphate band (1,200–930 cm−1, baseline: 1,200–930 cm−1) to the amide I band (1,720–1,600 
cm−1, baseline: 1,720–1,600 cm−1); mineral maturity (the ratio of apatitic to non-apatitic phosphate), 
estimated as the area ratio 1,030 cm−1 over 1,020 cm−1 peaks (baseline: 1,200–930 cm−1); and collagen 
maturity (the ratio of non-reducible to reducible collagen cross-links), estimated as the area ratio 1,660 
cm−1 over 1,690 cm−1 peaks (baseline: 1,720–1,600 cm−1). To resolve overlapping bands, the spectra were 
processed using PEAKFIT 4.12 (SeaSolve, San Jose, CA). Second derivative spectra, accompanied by 
9-data-point Savitsky–Golay smoothing, were calculated to identify the peak wavenumbers of component 
bands in the spectra. These wavenumbers, which are in close agreement with published data [37, 38], 
were used for curve fitting with Gaussian component peaks. The position, half-bandwidth and amplitude 
of the peaks were altered until the resulting bands shifted by no more than 3 cm−1 from the initial 
parameters and good agreements between the sum of all components and the experimental spectra were 
achieved (r2 > 0.999). 
 
Nanoindentation testing 
The PMMA-embedded specimens were subjected to nanoindentation testing by a dynamic 
ultra-micro-hardness tester (DUH-201S; Shimadzu, Kyoto, Japan) equipped with a diamond Berkovich 
tip; curvature radius < 100 nm. Three points were placed, maintaining a small distance from each other, in 
each square region where the chemical data were collected (Fig. 2A), and were tested with a trapezoidal 
loading waveform (Fig. 2C) having a maximum load of 6 mN with a loading/unloading rate of 300 µN/s, 
giving a time-to-peak force of 20 s and a 100-s holding period at the maximum load [39]. Mechanical 
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indices were calculated from the resulting force (P)–displacement (h) curve according to the method of 
Oliver and Pharr [40]. 
The indentation modulus, as a function of the local elastic modulus Especimen and Poisson ratio 
νspecimen of the specimen, is given by 
indentation modulus =
𝐸specimen
1 − specimen
2 = (
1
𝐸r
−
1 − tip
2
𝐸tip
)
−1
,                    (1) 
where Etip (1131 GPa) and νtip (0.07) are the elastic modulus and Poisson ratio of the diamond indenter, 
respectively, and Er is the reduced modulus. The latter was derived from the slope of a tangent S at the 
point of initial unloading (h = hmax) and the contact area Ac, which have a direct relationship with Er, 
𝑆 = 𝑆(ℎmax) =
𝑑𝑃
𝑑ℎ
|
ℎ=ℎmax
=
2
√𝜋
 𝐸r√𝐴c .                                                        (2) 
The ratio of maximum force Pmax (P at h = hmax) to Ac gives hardness, interpreted as a measure 
of strength, specifically resistance to non-elastic deformation under compression, i.e., 
hardness =
𝑃max
𝐴c
                                                                                                    (3) 
Statistics 
Data are presented as mean ± standard deviation. Chemical and mechanical indices were 
averaged over measurement points in each specimen. One-way analysis of variance (ANOVA) with 
Tukey’s post-hoc test was performed to analyze the difference between groups and two-way ANOVA to 
analyze the potential interaction between iPTH and WBV. Bartlett’s test and the F-test showed no 
statistical differences in variances between groups in all data sets. All data were analyzed by Prism 6 
(GraphPad Software; San Diego, CA), and a value of P < 0.05 was considered statistically significant. 
 
Results 
On the first day of interventions (2 weeks post-OVX), the c-OVX, p-OVX, w-OVX, pw-OVX 
and sham-OVX mice weighed 22.5 ± 0.8, 22.8 ± 0.6, 23.2 ± 0.9, 23.1 ± 0.8 and 20.7 ± 1.0 g, respectively. 
Average body mass was 11% higher in OVX mice (c-OVX, p-OVX, w-OVX, pw-OVX) than in 
sham-OVX mice. On the last day of interventions (1 month post-OVX), the c-OVX, p-OVX, w-OVX and 
pw-OVX mice weighed 22.8 ± 1.1, 22.8 ± 0.6, 23.0 ± 0.8 and 23.3 ± 0.9 g, respectively, showing an 
average body mass 7% higher than the sham-OVX mice, which weighed 21.6 ± 0.5 g. Body mass did not 
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differ between c-OVX, p-OVX, w-OVX and pw-OVX, indicating no impact of iPTH, WBV and their 
combination on body mass. 
The representative three-dimensional reconstruction of tibial bone structure is illustrated for 
each group in Fig. 1B, and the bone structural data are summarized in Table 1. All structural indices were 
smaller in the c-OVX than in the sham-OVX mice. Compared with sham-OVX, p-OVX and w-OVX still 
showed smaller values in all indices except for Tb.Cd in p-OVX, which, however, was similar to that in 
c-OVX. No differences were found in Tb.Th and Tb.Cd between sham-OVX and pw-OVX, although 
Tb.Vf, Tb.N and all cortical structural indices were still smaller in pw-OVX than in sham-OVX. 
Furthermore, pw-OVX showed higher Tb.Vf and Tb.Cd than did c-OVX. There was no significant 
interaction between WBV and iPTH for any structural index. 
Table 2 presents chemical and mechanical properties of cortical bone. There were no 
inter-group differences in mineral/matrix ratio or collagen maturity. Compared with sham-OVX, c-OVX 
and p-OVX showed less mineral maturity. Mineral maturity was similar in w-OVX, pw-OVX, and 
sham-OVX and was higher in pw-OVX than in c-OVX. Indentation modulus did not differ between 
groups but showed a decreased tendency in c-OVX compared with sham-OVX (P = 0.07). Hardness was 
smaller in c-OVX, p-OVX and w-OVX than in sham-OVX, higher in pw-OVX than in c-OVX, and 
similar in sham-OVX and pw-OVX. No significant interaction was found between WBV and iPTH for 
any chemical or mechanical index. 
Figure 3 shows the plots of the mineral maturity and hardness for each specimen. Linear 
regression analysis found a significant correlation in the pooled data of all groups but not within any 
single group. No correlation was found in any of the other pairs of chemical and mechanical indices in 
any group or the pooled data. 
 
Discussion 
This study was undertaken to determine whether the concurrent use of WBV and iPTH might 
have therapeutic potential against osteoporosis in a synergistic or additive manner. A single application of 
WBV or iPTH was not effective against osteoporotic bone loss in OVX mice. When the two treatments 
were combined, however, OVX-induced reductions in trabecular bone volume and connectivity abated. 
The efficacy of WBV and iPTH in combination was also observed in cortical bone hardness and mineral 
maturity, both of which reduced in OVX mice but recovered to the healthy control levels. Considering 
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there was no interaction between the two treatments in any structure, chemical or mechanical index, the 
combined treatment might be additive rather than synergistic. 
Compared with sham-OVX mice, OVX mice showed smaller trabecular bone volume fraction, 
thickness, number density and connectivity density. Cortical bone and medullary tissue volumes and 
cortical thickness were also smaller in OVX mice than in sham-OVX mice. These declines in bone 
structural indices in parallel with increased body mass are in line with previous studies using OVX mice 
[14, 41–44], confirming the onset of osteoporosis one month after OVX treatment. In addition, 
OVX-induced decreases in mineral maturity and hardness with a trend towards a declined indentation 
modulus were observed at metaphyseal cortical bone. The increased proportion of immature crystals 
observed here was also found in women during menopause [45], although there has been no study 
documenting these chemical and mechanical properties in OVX mouse bone. The short-term effects of 
OVX on intrinsic bone material properties have been examined only in femoral cortical bone of rabbits at 
4 weeks post-OVX [46], which included a smaller mineral/matrix ratio, higher mineral maturity, higher 
collagen maturity, lower indentation modulus and lower hardness compared with the age-matched healthy 
rabbits. Differences to the present results, most notably the opposite trend for mineral maturity, could be 
due to OVX models of different ages and species (young adult mice vs. mature adult rabbits) or skeletal 
site-specific effects of OVX (tibial proximal metaphysis vs. femoral diaphysis) [47]. There are also 
inconsistencies between other reports on the longer-term OVX effect on mineral maturity [46, 48, 49]. 
No significant difference was found in any structure, chemical or mechanical index between 
untreated and iPTH-treated OVX mice, showing the insufficient anabolic effect of iPTH alone. In OVX 
mice of the same strain, however, iPTH improved tibial bone mineral and structure [42, 50, 51]. In these 
studies, the daily PTH (1–34) dose (40–80 µg/kg) was slightly higher, and durations to onset of iPTH 
after OVX (4–6 weeks) and of iPTH treatment (3–4 weeks) were longer than those in the current study (2 
weeks after OVX to onset of 30-µg/kg/day PTH over 18 days). On the other hand, a daily dose of 
100-µg/kg PTH (1–84), equivalent to 40-µg/kg PTH (1–34), over 2 weeks after the introduction of OVX, 
did not affect tibial bone structure in OVX mice of the same strain [52]. Differences in experimental time 
frame or OVX-induced estrogen status [53] may be responsible for the variable anabolic efficacy of iPTH 
in OVX mice. 
Likewise, 18-day WBV alone was not effective against osteoporosis, although bone 
mechano-responsiveness will be elevated in OVX-induced estrogen deficiency [21–23]. There have been 
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no studies investigating the effect of WBV in OVX mice. In a study exposing 8-week-old female BALB/c 
mice to WBV (15 min/day, 5 day/week) with the same vibration settings as in the present work, Xie et al. 
[32] showed a decline in osteoclastic activity in tibial trabecular bone and an increase in bone formation 
rate on the tibial endocortical surface during the first 3 weeks. They also reported that another 3 weeks 
were needed for the same daily WBV to yield significant effects in cortical bone geometry [54]. Chen et 
al. treated 8-week-old OVX rats with a similar WBV protocol (45–55 Hz, 0.3 g; 20 min/day, 5 day/week), 
starting the day after OVX introduction, and observed no effect during the first 4 weeks followed by 
improvement of tibial trabecular bone structure during the next 8 weeks [55]. Thus, at least in the current 
daily WBV protocol, a longer-term application would be required to produce skeletal changes in a 
detectable fashion. 
 There has been only one study on the therapeutic potential of combining WBV with iPTH 
against low-bone mass [56], in which 4- or 8-week concurrent use of WBV (90 Hz, 0.3 g; 15 min/day, 5 
day/week) and iPTH (1–34) (10- or 40-µg/kg/day) was shown to be no more effective than either single 
use alone in tibiae of 7-month-old male BALB/c mice. In contrast, the present 18-day treatment of WBV 
and iPTH in combination for OVX mice reduced osteoporotic trabecular bone loss and disconnectivity, 
and restored cortical bone hardness and mineral maturity to the healthy control levels although either 
treatment alone showed no skeletal effect. These outcomes may be due to the simultaneous elevation of 
osteoblast number [11] and bone mechano-responsiveness [21-23] caused by iPTH and OVX-induced 
low estrogen levels. The discrepancy between the two studies may also be attributed to differences in 
WBV frequency, strains and age [57–59]. Cortical bone structure remained unaffected, even by the 
combined treatment. A different metabolic turnover, which is faster for trabecular than for cortical bone 
[60], may play a role in the different treatment outcomes in trabecular and cortical bone. A longer-term 
study is needed to confirm the combined action of WBV and iPTH on cortical bone structure. 
Early studies [61, 62] demonstrated the effectiveness of WBV in reducing high bone turnover 
where bone resorption exceeds bone formation. Thus, iPTH-induced activation of WBV could lower bone 
turnover or bone resorption that may be elevated because of OVX [5, 6]. A decrease in bone resorption 
allows bone tissues to persist longer and favors bone maturation. Higher mineral maturity may be 
associated with higher hardness in cortical bone of WBV/iPTH-treated OVX mice, as indicated by the 
positive correlation between hardness and mineral maturity (Fig. 3). However, mineral maturity, defined 
here as the ratio of apatitic to nonapatitic phosphate, evolves concomitantly with mineral crystal size and 
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crystalline perfection but possibly with different kinetics [63, 64]. Furthermore, other properties at the 
crystal level, such as alignment of bone apatite crystallites and interactions between mineral and collagen, 
will be involved in cortical bone hardness. Thus, although the combined treatment of WBV and iPTH 
improved the material properties of bone tissue to the healthy control levels, further study is needed to 
clarify the mechanisms by which chemical alterations to bone tissue affect their mechanical properties. 
 There are some limitations to be noted. First, we used only a single WBV protocol. The skeletal 
effect of WBV varies with vibration frequency and magnitude [57, 65]. Thus, although no improvement 
was found in bone structure or in material properties in WBV-treated OVX mice, there may be a more 
favorable vibration setting for WBV to elicit therapeutic effects independently of iPTH or to provide 
additional benefits when used concurrently with iPTH. Second, we used single-time-point data during 
early-stage osteoporosis and assessed only short-term effects of treatments. Multi-time-point data over a 
longer duration of osteoporosis are necessary for demonstrating the therapeutic efficacy of WBV and 
iPTH in combination. Finally, we did not perform dynamic bone histomorphometry during treatments, 
and therefore, we could not determine whether the WBV/iPTH-induced benefits to trabecular bone 
structure were attributed to its anabolic or anti-catabolic action. 
 In conclusion, 18-day treatment of WBV combined with iPTH was additively effective in 
improving trabecular bone structure and material properties of cortical bone at an early stage of 
OVX-induced osteoporosis in mice, suggesting its potential for treating postmenopausal osteoporosis. 
Further study is required for assessing its long-term therapeutic potential and for identifying an optimal 
WBV protocol, possibly combined with a clinically feasible PTH dosage.  
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Table 1   Bone structural indices 
 
sham-OVX c-OVX p-OVX w-OVX pw-OVX 
Tb.Vf [%] 8.96±1.58 6.00±0.64a 6.84±0.78a 6.68±0.51a 7.21±0.46a,b 
Tb.Th [µm] 44.2±4.0 40.4±2.1a 41.0±2.2a 40.9±1.9a 41.7±1.1 
Tb.N [mm-3] 1496±229 1054±143a 1145±184a 1101±161a 1225±200a 
Tb.Cd [mm-3] 173.2±44.1 92.7±38.0a 128.1±42.7 118.2±33.8a 144.3±37.3b 
Cb.V [mm3] 1.38±0.16 1.08±0.09a 1.11±0.07a 1.10±0.07a 1.17±0.05a 
Cb.Th [µm] 128.5±10.4 106.9±7.5a 110.6±8.5a 107.1±7.2a 111.6±5.6a 
Mt.V [mm3] 3.22±0.46 2.52±0.13a 2.46±0.13a 2.50±0.12a 2.55±0.13a 
aP<0.05 vs. sham-OVX, bP<0.05 vs. c-OVX 
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Table 2   Chemical and mechanical properties of cortical bone 
 
sham-OVX c-OVX p-OVX w-OVX pw-OVX 
mineral/matrix ratio 7.80±0.74 7.67±0.99 8.32±0.96 8.08±0.85 7.92±0.68 
mineral maturity 1.57±0.14 1.27±0.15a 1.30±0.19a 1.39±0.13 1.51±0.21b 
collagen maturity 5.71±1.11 4.64±1.01 5.07±1.42 4.75±1.15 4.97±1.43 
indentation modulus [GPa] 17.95±2.90 13.72±4.81 15.71±2.39 14.94±2.15 15.39±3.57 
hardness [GPa] 1.05±0.25 0.57±0.19a 0.75±0.11a 0.74±0.08a 0.90±0.16b 
aP<0.05 vs. sham-OVX, bP<0.05 vs. c-OVX 
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Figure captions 
Figure 1. (A) Projection of the reconstructed three-dimensional volume of proximal tibial bone, 
showing a region for structural analysis defined by a volume extending a distance of 1.5 mm 
distal to the growth plate. Dashed line shows the transverse section evaluated for FTIR-MS 
and nanoindentation testing. (B) Three-dimensional metaphyseal tibial images, segmented 
into trabecular and cortical bone. Images were selected from mice having near-mean values 
of trabecular bone volume fraction in each group 
 
Figure 2. (A) Metaphyseal cross-sectional image at a polished cut surface, showing regions for 
FTIR-MS and indents by nanoindentation testing. Each of four regions measured for FTIR 
spectra include three indents. (B, C) Examples of FTIR spectra after 9-data-point smoothing 
and baseline correction (left) and a force–displacement curve during a 
loading-holding-unloading process (right) 
 
Figure 3. Plots of hardness vs. mineral maturity. Each plot represents the mean of all data in a single 
specimen. Pooled data show the significant correlation between hardness and mineral 
maturity 
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